USRM
U S STEM CELL INC
stockOTC
u.s. stem cell, inc. is a leader in regenerative medicine and is committed to providing autologous cell therapies for the treatment of degenerative conditions. the company specializes in the development of proprietary, physician-based stem cell therapies; novel regenerative solutions, including its lead product adipocell™; physician training and certification; veterinary applications; stem cell banking; as well as creating and managing new stem cell clinics. in the past 20 years, to the company's knowledge, u.s. stem cell, inc. has completed more clinical treatments than any other regenerative care provider in the world. with more than 700 physicians trained and certified with the company, u.s. stem cell, inc. boasts the largest network of physicians working together to continue its mission of harnessing the body's own ability to heal from within to treat a wide variety of conditions and to improve quality of life.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.00 | 2026-09-29 | +9900.00% | 0.000 |
| 2Y | 0.00 | 2024-10-02 | +9900.00% | — |
| 5Y | 0.01 | 2021-10-04 | -99.23% | -93.533 |
U S STEM CELL INC (OTC:USRM) stock price today is $0.00, and today's volume is 63,000. USRM is up 9900.000% today. The 30 day average volume is 216,758. USRM market cap is $66,151 with 661.51M shares outstanding.